Purchase Order 75N93020P00528
Award Date 4/21/20
Potential Completion Date 5/20/20
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The $16,199.95 contract is for the delivery of BIOLEGEND antibodies to support NIAID's research initiatives, which may include studies related to COVID-19, immunology, and other disease areas. The contract does not...
- This firm-fixed-price federal purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical products. The $31,957.50 contract supports the supply of various antibodies, reagents, and kits to advance research initiatives across NIAID, with no set-aside designation. Biolegend has a long history of providing specialized products for...
- This is a $98,517.25 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other products supporting life science research and drug discovery. The contract, awarded on January 28, 2021, is for the procurement of COVID-19 research antibodies, with a period of performance through January 26, 2022....
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a firm-fixed-price purchase order contract worth $8,377.50 to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The contract is for the delivery of "Brilliant Violet Anti-Human Antibodies" to support the agency's research efforts. Biolegend, Inc. is a subsidiary of the parent company Revvity Inc. This contract...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Biolegend, Inc., a for-profit manufacturer of biomedical research products. The contract, valued at $7,190.00, is for the delivery of antibodies. There is no set-aside designation for this contract. Biolegend, Inc. is the prime contractor and has not...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Biolegend, Inc. for the supply of various biomedical research reagents and antibodies. The $3,088.75 contract supports research efforts across multiple federal agencies, particularly within the NIAID. Biolegend, a for-profit manufacturer of life science research products, has a history of providing specialized...
- Biolegend, Inc. has been awarded a firm fixed price purchase order contract valued at twenty-four thousand five hundred sixty-one dollars and seventy-five cents ($24,561.75) by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for the delivery of BIOLEGEND ANTIBODIES with performance through September 30, 2023. As a manufacturer of biomedical reagents, antibodies, proteins, and other products to...
- <p>The National Institute of Allergy and Infectious Diseases (NIAID) awarded a purchase order to Biolegend, Inc. for antibodies with a ceiling value of $12,042.50 on September 2, 2020, with an ultimate completion date of October 2, 2020. No set-aside was used. Performance takes place in San Diego, California. The order is firm fixed price for commercial antibody products supplied by Biolegend, a biomedical reagents manufacturer.</p>
- This is a firm-fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc. The contract is for the delivery of various antibodies and related biomedical reagents to support research efforts. The contract has a ceiling value of $4,286.20 and an ultimate completion date of July 1, 2016. Biolegend, Inc. is a for-profit manufacturer and supplier of biomedical products, with...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $22,041.90 purchase order to Biolegend, Inc., a medical division of Revvity Inc., for BIOLEGEND ANTIBODIES. The firm fixed price order runs from September 1, 2023 through October 31, 2023 for place of performance in San Diego, California. No major subcontractors or set aside designations were indicated. This small purchase supports the NIH/NIAID's research...